Institute of Cancer Research: the Royal Cancer Hospital Lbg

Institute of Cancer Research: the Royal Cancer Hospital Lbg is a university in London, United Kingdom that has taken part in 50 EU-funded projects since 2008, receiving €17.0M in EU funding and leading 17 as coordinator.

EU funding received€17.0M
EU projects50
As coordinator17
Running now10
First EU project2008
Latest project2027
CountryUnited Kingdom
EU registration (PIC)999460841
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Institute of Cancer Research: the Royal Cancer Hospital Lbg's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€8.2M · 24 projects
  • Horizon 2020€5.6M · 16 projects
  • Horizon Europe€3.3M · 10 projects

Projects

50 EU-funded projects, newest first. Institute of Cancer Research: the Royal Cancer Hospital Lbg led 17 of them as coordinator. Each links to the official record.

  • dIscOverNETPartner

    Developing Immune Strategies to Counter tumor-immune-micrOnVironmEntal Resistance in NeuroEndocrine Tumors.

    Horizon Europe · 2027–2030 · Project on CORDIS ↗

    €697ktheir share
  • ORFeusPartner

    Decoding the dark proteome through interdisciplinary training and research

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €349ktheir share
  • OCTOPOD-Ph2aPartner

    A Novel Phase-2a Clinical Trial for a Next-Generation Oncolytic Immunotherapy Targeting Platinum-Resistant Ovarian Cancer

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €651ktheir share
  • B-REDiTxCoordinator

    Optimising cancer therapy scheduling through personalised mechanistic models and reinforcement learning

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €260ktheir share
  • EvoMG-DNPartner

    Evolutionary Medical Genomics Doctoral Network

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €697ktheir share
  • HER-CAREPartner

    Hereditary and Early onset breast cancer: Comprehensive personalized Assessment, early Risk Evaluation, and clinical management

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €349ktheir share
  • INTERACTAssociated partner

    Interdisciplinary Marie Skłodowska-Curie Action for Health

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

  • EVOBREASTCoordinator

    Uncovering immunoediting strategies underlying malignant transformation in breast tissues

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €260ktheir share
  • AdaptmetAssociated partner

    Deconstructing adaptive evolution of metastasis

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • MONALISAAssociated partner

    A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

  • EvometPartner

    Deconstructing the evolution of metastasis

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €303ktheir share
  • VAGABONDPartner

    Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €303ktheir share
  • UBIMOTIFPartner

    Short linear interaction motifs as specificity determinants in the ubiquitin system – discovery, mechanisms and therapeutic opportunities

    Horizon 2020 · 2019–2024 · Project on CORDIS ↗

    €303ktheir share
  • EVOMETCoordinator

    The rise and fall of metastatic clones under immune attack

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €225ktheir share
  • CANCEREVOPartner

    Deciphering and predicting the evolution of cancer cell populations

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

    €750ktheir share
  • FURTHERPartner

    Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients with Bone Metastasis

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

    €450their share
  • UCOMPartner

    Ultrasound Cavitation in Soft Materials

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €606ktheir share
  • COLOSSUSPartner

    Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €295ktheir share
  • CONTRAPartner

    Computational ONcology TRaining Alliance

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €273ktheir share
  • DRIVEPartner

    Driving next generation autophagy researchers towards translation

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €273ktheir share
  • ITCC-P4Partner

    ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €647ktheir share
  • REDOXCYCLECoordinator

    The molecular interface between cell cycle and redox regulation

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €236ktheir share
  • FORCEPartner

    Imaging the Force of Cancer

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €632ktheir share
  • EMCOP9CRLCoordinator

    Structural basis of Cullin-RING ligase regulation by the COP9 signalosome

    Horizon 2020 · 2015–2017 · Project on CORDIS ↗

    €183ktheir share
  • B-CASTPartner

    Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes

    Horizon 2020 · 2015–2021 · Project on CORDIS ↗

    €383ktheir share
  • Human Rpc5Coordinator

    RNA Polymerase III Rpc4/Rpc5 subcomplex and Selenocysteine tRNA transcription

    Horizon 2020 · 2015–2017 · Project on CORDIS ↗

    €183ktheir share
  • BARCODECoordinator

    The use of genetic profiling to guide prostate cancer targeted screening and cancer care

    FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

    €2.5Mtheir share
  • RESICT-PCCoordinator

    Studying Resistance to Cancer Therapeutics in Prostate Cancer

    FP7 (2007 to 2013) · 2014–2016 · Project on CORDIS ↗

    €231ktheir share
  • CDELPCoordinator

    CHD1 Deletion: Implications to Outcome and Treatment in Prostate Cancer

    FP7 (2007 to 2013) · 2014–2016 · Project on CORDIS ↗

    €231ktheir share
  • LIVERNCODECoordinator

    Transcribed-Ultraconserved Regions as novel biomarkers and therapeutic targets in liver cancer

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €93ktheir share
  • TAMIRCRTCoordinator

    Targeting microRNAs for ColoRectal Cancer Therapy

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €9ktheir share
  • DECIDEPartner

    Decision-making within cells and differentiation entity therapies

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €285ktheir share
  • CELARPartner

    CELAR: Automatic, multi-grained elasticity-provisioning for the Cloud

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €6ktheir share
  • CTCTRAPPartner

    Circulating Tumor Cells TheRapeutic APheresis: a novel biotechnology enabling personalized therapy for all cancer patients

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €636ktheir share
  • ICRMYELOMACoordinator

    Sequence of Mutational Events and Sub-clonal Architecture in Plasma Cell Myeloma

    FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗

    €209ktheir share
  • QUIC-CONCEPTPartner

    QUantitative Imaging in Cancer: CONnecting CEllular Processes with Therapy

    FP7 (2007 to 2013) · 2011–2018 · Project on CORDIS ↗

    €561ktheir share
  • ECNIS2Partner

    ECNIS2: towards ECNIS Centre for Research and Education on Cancer, Environment and Food

    FP7 (2007 to 2013) · 2011–2013 · Project on CORDIS ↗

  • Melanoma InvasionCoordinator

    Molecular mechanisms of melanoma invasion

    FP7 (2007 to 2013) · 2011–2013 · Project on CORDIS ↗

    €210ktheir share
  • pARylomeCoordinator

    pARylation-mediated regulation of cancer pathways

    FP7 (2007 to 2013) · 2011–2013 · Project on CORDIS ↗

    €30ktheir share
  • DDRESPONSEPartner

    The DNA damage response and breast cancer

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €686ktheir share
Show 10 more projects
  • SYSCOLPartner

    Systems Biology of Colorectal Cancer

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €853ktheir share
  • EUROCANPLATFORMPartner

    A European Platform for Translational Cancer Research

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €226ktheir share
  • BASISPartner

    Breast Cancer Somatic Genetics Study

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €91ktheir share
  • HER2 MAMMARYSTEMCELLCoordinator

    The influence of Her2 status on mammary stem/progenitor cells

    FP7 (2007 to 2013) · 2009–2011 · Project on CORDIS ↗

    €172ktheir share
  • SAGHEPartner

    Safety and Appropriateness of Growth hormone treatments in Europe

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €152ktheir share
  • COGSPartner

    Collaborative Oncological Gene-environment Study

    FP7 (2007 to 2013) · 2009–2014 · Project on CORDIS ↗

    €601ktheir share
  • EPOCPartner

    European Paediatric Oncology Off-Patent Medicines Consortium

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

  • SYNTHLE BRCACoordinator

    Synthetic lethality approaches to BRCA-associated cancer

    FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗

    €169ktheir share
  • 03KPartner

    Oral Off-patent Oncology Drugs for Kids

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €54ktheir share
  • BASAL BREAST CANCERCoordinator

    Characterization of myoepithelial differentiation in basal-like breast cancer cells

    FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗

    €169ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • RNA
  • antibiotic resistance
  • basal cells
  • biochemistry
  • breast cancer
  • cell biology
  • cell signaling
  • colorectal cancer
  • comets
  • computational science
  • crystallography
  • data science
  • databases

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime